Interestingly, 39 of them were involved in cancer-related molecular pathways (ATXN2, AXIN1, BCL2L11, CAMK2B, CDH15, CDH17, CHUK, COL1A1, COL4A6, COL7A1, CSNK1G1, CTGF, CXCL12, CXCL6, FGF11, FGF5, FZD5, GABRA1, GNAS, GNRH2, HAPLN1, IHH, INSRR, ITGB2, LAMB2, LIFR, MAPK10, MUC1, PIK3R1, PPARGC1A, PSMA7, PTCH1, PTK7, SHC3, TCF4, TGFB2, TNFRSF14, TUBGCP2, and ZEB1). Here, CDH17 is linked to cancer.